DR

Deepak Raj Kandathadathil

Active Director Director DIN 08060916
DIN 08060916 First appointment Jan 2018 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepak Raj Kandathadathil

Data last updated:

Deepak Raj Kandathadathil is a Director at Biofocuz Pharma Private Limited (since 2018). The company operates in Trading.

DIN 08060916
Primary Designation Director
Industry Trading
First Appointment 11 Jan 2018
Oldest Company Age 14 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biofocuz Pharma Private Limited U51397KL2012PTC031239
Director11 Jan 20182012Active

Board colleagues of Deepak Raj Kandathadathil

Directorship timeline

Open interactive timeline →
Biofocuz Pharma Private Limited
Premium access

Shareholding and investment profile for Deepak Raj Kandathadathil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Raj Kandathadathil

Deepak Raj Kandathadathil currently holds 1 directorship: Biofocuz Pharma Private Limited (Director, since 11 Jan 2018).

Deepak Raj Kandathadathil was first appointed on 11 Jan 2018 as Director at Biofocuz Pharma Private Limited.

The current boards of Deepak Raj Kandathadathil's companies include Gopesh Veluthadath (Biofocuz Pharma Private Limited), Padmakumar (Biofocuz Pharma Private Limited), Unnimadhavan Nair (Biofocuz Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available